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The t(14;18) chromosomal translocation is the most common translocation in human cancer, and it occurs
in all follicular lymphomas. The 150-bp bcl-2 major breakpoint region (Mbr) on chromosome 18 is a fragile
site, because it adopts a non-B DNA conformation that can be cleaved by the RAG complex. The non-B DNA
structure and the chromosomal translocation can be recapitulated on intracellular human minichromosomes
where immunoglobulin 12- and 23-signals are positioned downstream of the bcl-2 Mbr. Here we show that
either of the two coding ends in these V(D)J recombination reactions can recombine with either of the two
broken ends of the bcl-2Mbr but that neither signal end can recombine with the Mbr. Moreover, we show that
the rejoining is fully dependent on DNA ligase IV, indicating that the rejoining phase relies on the nonho-
mologous DNA end-joining pathway. These results permit us to formulate a complete model for the order and
types of cleavage and rejoining events in the t(14;18) translocation.
Antigen receptor loci recombine V, D, and J segments to
create exons that encode the variable domains of immuno-
globulins and T-cell receptors. The recombination is catalyzed
by the RAG complex, consisting of RAG1, RAG2, and HMG1.
The RAG complex binds to signal sequences adjacent to the V,
D, and J segments. These signal sequences consist of a palin-
dromic heptamer and an A/T-rich nonamer, separated by ei-
ther a 12- or a 23-bp spacer. One recombination event consists
of the action of the RAG complex on a pair of signals, one with
a 12-bp spacer (designated a 12-signal) and the other with a
23-bp spacer (designated a 23-signal). After double-strand
cleavage, there are four DNA ends: a 12-signal end, a 23-signal
end, and two coding ends (designated the 12- and 23-coding
ends to indicate to which signal each coding end was formerly
attached) (7, 13). The two signal ends are joined together, and
the two coding ends are joined together, all using the nonho-
mologous DNA end-joining pathway (NHEJ) (23, 25).
NHEJ begins with the binding of Ku to the DNA ends. Ku
recruits a nuclease complex consisting of Artemis and the
DNA-dependent protein kinase catalytic subunit (DNA-PKcs).
The Artemis–DNA-PKcs complex opens the DNA hairpins
that are formed at the coding ends during the RAG cleavage
process (26). This complex also trims 5 and 3 overhangs
during the end processing of NHEJ. The XRCC4-DNA ligase
IV complex ligates the two signal ends together, typically with-
out nucleotide loss, to form a signal joint (15, 35). The two
coding ends are joined together with nucleotide loss (due to
nuclease action) and with template-independent nucleotide
addition, due to terminal deoxynucleotidyl transferase (TdT)
(25), all contributing to junctional diversification.
The t(14;18) translocation is the single most common trans-
location in human cancer, occurring in all follicular lymphomas
and in a subset of other lymphomas (2, 3, 5, 19, 29, 34, 36). The
break at chromosome 18 occurs within the bcl-2 gene, primar-
ily within a 150-bp region called the major breakpoint region
(Mbr) (19, 29, 36). The events at chromosome 14 begin with
cuts at the D and J segments. However, instead of the D end
being joined to the J end, the D end is joined to the down-
stream end of the bcl-2 Mbr break, and the J end is joined to
the upstream end of the bcl-2 Mbr break (Fig. 1) (20, 21, 29).
It has been unclear why the bcl-2 Mbr is so precisely focused
to this 150-bp region and what proteins cause the break. Re-
cently, we showed that the bcl-2 Mbr adopts a non-B DNA
structure and that the RAG complex cleaves within this non-B
DNA region. We showed that many aspects of the t(14;18)
translocation can be recapitulated on a human minichromo-
some (30). The non-B DNA conformation of the Mbr is stable
and can be recapitulated on bacterial plasmids and even on
shorter PCR fragments (28, 30).
Despite this progress, many questions remain. Once the breaks
at the D and J segments occur, can any of the four ends (two
signal and two coding ends) recombine with the two ends of the
Mbr? Can either of the two coding ends (D or J) recombine with
either end of the Mbr, or are there constraints intrinsic to the
manner of breakage? Are all six DNA ends (two signal, two
coding, and two Mbr ends) rejoined simultaneously, or are some
ends rejoined before others (Fig. 1)? Finally, what is the pathway
of rejoining? Here, we address each of these questions.
MATERIALS AND METHODS
Oligonucleotides. Oligomers are from QIAGEN/Operon (Richmond, CA) or
from the USC Norris Cancer Center Microchemical Core Facility. The following
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oligomers were used in this study: SCR21, 5-AGTGCCACCTGACGTCTAA
G-3; GHG1, 5-GAACGGTCTGGTTATAGGTAC-3; SCR97, 5-CGCGTCC
CATTCGCCATTC-3; SCR98, 5-CAATACGCAAACCGCCTCTCC-3; XW8,
5-AGCGTCGACCCTTTAGAGAGTTGCTTTACG-3; XW9, 5-GCTGTCG
ACCTCGAGTAGCAGCACAGGATTGGATAT-3; KY28, 5-GATCAGCTG
ATAGCTACCACAGTGCTACAGACTGGAACAAAAACCCTGCT-3; KY29, 5-
TAGCAGGGTTTTTGTTCCAGTCTGTAGCACTGTGGTAGCTATCAGCTGA
T-3; KY36, 5-GATCAGCTGACAGTAGCACAGTGGTAGTACTCCACTCTCT
GGCTGTACAAAAACCCTGCT-3 ; KY37, 5-TAGCAGGGTTTT
TGTACAGCCAGAGAGTGGAGTACTACCACTGTGCTACTGTCAGCTGA
T-3; SCR116, 5-GACCTGCCGAGTGGTTCAGCAGG-3; SCR173, 5-CCT
GTTGACAATTAATCATC-3; SCR199, 5-GTTTTTGTTCCAGTCTGTAGC
AC-3; SCR200, 5-CAGACAGTGGAGTACTACCAC-3; SCR201, 5-CTCG
CCAAGCTGATCCCCGG-3; and SCR202, 5-CCTAGTTAACTATACGCA
GC-3.
The oligomers were purified using 8 to 15% denaturing polyacrylamide gel
electrophoresis. The complementary oligomers (or DNA strands) were annealed
in 100 mM NaCl and 1 mM EDTA by heating them in a beaker of boiling water
for 10 min, followed by slow cooling.
Plasmid construction. The plasmid constructs were made by modifying the
simian virus 40-based plasmid, pGG51, pGG49, or pGG52 (11). A SalI-digested,
300-bp PCR fragment of the bcl-2 Mbr was cloned into a SalI-digested pGG51
(pXW5). In pXW6, the bcl-2 Mbr is in the opposite orientation (30). Plasmid
pSCR1 was constructed by cloning the 300-bp SalI fragment into the SalI site of
pBSS3, a derivative of a Bluescript plasmid in which the lacZ promoter has been
deleted (30).
A 167-bp fragment containing 12- and 23-signals was cloned into pXW5 after
replacing the existing 23-signal fragment to construct pSCR45 (30). A weak
prokaryotic transcriptional terminator is present between the 12- and 23-signals
of pSCR45. In order to remove this weak terminator, a 354-bp lambda fragment
was cloned into the ClaI site of pGG51, pGG49, and pGG52. A 497-bp SpeI-
SmaI fragment, containing the two signals and the 354-bp lambda fragment, was
then cloned into pXW5 after replacing the 23-signal by BamHI digestion. The
new constructs generated are pSCR71, pSCR72, pSCR73, pSC74, pSCR75, and
pSCR76 (Fig. 2A and B). The plasmids pSCR77, pSCR79, pSCR81, pSCR85,
and pSCR87 are the same as pSCR71, pSCR72, pSCR73, pSCR75, and pSCR76,
respectively, except that the bcl-2 Mbr is in the reverse orientation.
Human V(D)J recombination assay. The human lymphoid cell line Reh was
grown logarithmically, transfected with the appropriate plasmid substrates by
using the electroporation/DEAE-dextran method described previously (8), and
cultured for 48 h at 37°C. In some experiments, Nalm6 cells or N114P2 cells
(which are genetically null for ligase IV and are derived from the Nalm6 cell line)
were also used for transfection (16). The various steps involved in the human
V(D)J recombinase assay were described previously (9, 11, 12). In brief, episo-
mal DNA was harvested from mammalian cells after 48 h of incubation at 37°C
by a rapid alkaline harvest method. The DNA was recovered and resuspended in
50 l of Tris-EDTA (pH 8.0). The recovered DNA was then transformed into
Escherichia coli, with or without DpnI digestion (to quantitate eukaryotic repli-
cation), for further analysis. The recombinants (Fig. 2A) recovered on chloram-
phenicol-ampicillin doubly resistant plates were further examined by extracting
the episomal DNA and by DNA sequencing. Sequencing reactions were carried
out using a SequiTherm Excel II sequencing kit (Epigenetics) and an MWG
thermal cycler, model Primus 96 Plus (MWG Biotech, High Point, NC). Auto-
mated sequencing was carried out using a Li-Cor DNA analyzer, model 4200
(Li-Cor, Lincoln, NE). The recombinant plasmids conferred resistance to ampi-
cillin (designated A) alone and to ampicillin and chloramphenicol (designated
FIG. 1. Six DNA ends are generated during the t(14;18) translocation involving the Ig heavy-chain locus and bcl-2. The D and J segments at
the Ig heavy-chain locus on human chromosome 14 are shown in this diagram, and the DNA for this locus is indicated by double lines. The
downward vertical arrows mark where the V(D)J recombination process creates DSBs. The open and stippled triangles at the Ig heavy-chain locus
represent the heptamer/nonamer recombination signal sequences. Open triangle, 12-signal; stippled triangle, 23-signal. The DNA between the two
signals is normally joined to form a signal joint, and the D and J segments are joined together to form a coding joint. In the t(14;18) translocation,
the D and J segments fail to join together. In addition to this error in the process, a break occurs at the 3 untranslated region exon of the bcl-2
gene (ends indicated by a and b). Therefore, during the t(14;18) translocation, six different ends are generated (two Mbr ends, two signal ends,
and two coding ends). The order of joining between the ends is unclear, as reflected by the question marks. The final products of the t(14;18)
translocation are shown as the derivative chromosome 18 (left) and the derivative chromosome 14 (right). The J subexon joins with the 3 end (end
a) of the bcl-2 gene, and this joining leads to the upregulation of the bcl-2 gene and follicular lymphoma. The derivative chromosome 18 is
generated by joining of the D subexon and the 5 end (end b) of the bcl-2 gene. The pathway of all of the joining is unclear.
6476 RAGHAVAN ET AL. MOL. CELL. BIOL.
 o
n
 February 3, 2017 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
FIG. 2. In vivo distribution of breakpoints on extrachromosomal substrates, which cluster within the bcl-2 Mbr and at the recombination signal
sequences. (A) Depiction of a recombination substrate (pSCR71) and its recombination product (pSCR71 recombinant) derived after the joining
between the bcl-2 Mbr and a 23-signal. (B) The episomes (pSCR71 through pSCR76) were transfected into mammalian cells (Reh cells), recovered
48 h later, and analyzed in bacteria, as described in Materials and Methods. The fraction of the recombinants cleaved within the bcl-2 Mbr and
at the 12- or 23-signal is also shown. Designation of a cleavage event “at the 12- or 23-signal” means that the recombination occurred within 13
bp of the coding end proximal to the adjacent C nucleotide of the heptamer. In normal V(D)J recombination, over 98% of the recombination
points within the coding end are within 13 bp of the heptamer (11). In both panels, the Mbr regions are represented by black within the boxes.
The white regions within the boxes correspond to the DNA that is outside of the Mbr but which is the flanking DNA that is naturally adjacent to
the Mbr in the human chromosome. The 12- and 23-signals are indicated by the open and shaded triangles, respectively. The transcriptional
promoters are indicated by arrows. A 354-bp fragment of DNA from bacteriophage lambda serves as a spacer between the 12- and 23-signals and
is indicated by . “Stop” indicates the region of a prokaryotic transcription terminator, and “cat” represents the chloramphenicol gene.
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AC). The ratio of AC colonies to A colonies reflects the fraction of recovered
substrates that underwent V(D)J recombination. A more meaningful ratio can
be obtained by focusing on those ampicillin-resistant molecules that have under-
gone replication in the mammalian cells (24). The ratio of AC to A among
replicated molecules is determined by the equation R  (DAC/DA)  100,
where DAC is the number of transformants that arose because of transformation
with replicated recombinant molecules, DA is the number of transformants that
arose from any replicated plasmid, and R represents the recombination fre-
quency of the substrate. We controlled for replication by digesting the recovered
substrates with DpnI before bacterial transformation. DpnI cleaves the plasmid
molecules that did not lose their prokaryotic Dam methylation pattern by rep-
lication in eukaryotic cells. Only molecules that replicated in eukaryotic cells
(DA) remain undigested by DpnI and can transform the bacteria. The replica-
tion frequency of a given substrate is calculated by use of the equation (DA/A)
 100. Each eukaryotic transfection was typically analyzed with 10 to 20 E. coli
transformations to determine R [(DAC/DA)  100]. The average number of
multiple eukaryotic transfections of the same substrate in Reh cells was calcu-
lated by summing the total DAC counts (after restriction analysis and sequencing
verification of representative transformants) and dividing that total by the total
number of transformants from replicated plasmids (DA). The resulting number
is expressed as a percentage and is the weighted average [R  (DAC/DA) 
100].
RESULTS
In vivo tests for 12- or 23-coding-end recombination with the
bcl-2Mbr. Recombination between the bcl-2 Mbr and signal or
coding ends can be detected by using a human V(D)J recom-
bination assay. Previously, we reported that recombination be-
tween the bcl-2 Mbr and the 23-coding end is dependent on the
RAG1 and RAG2 proteins (30). In the present study, we
examined other possible end-joining combinations and re-
quirements of the t(14;18) translocation by using a series of
minichromosomes that carry the bcl-2 Mbr and 12/23-signal
pairs in various orientations (Fig. 2B). The Mbr and signal
sequences are separated by a prokaryotic transcriptional ter-
minator. If recombination occurs between either of the signal
ends and the Mbr, then the transcription terminator will be
deleted, resulting in chloramphenicol resistance (Fig. 2A).
The episome pSCR71 or pSCR72 was transfected into the
mammalian pre-B-cell line Reh (known to have high levels of
RAG expression) and harvested after 48 h. The replication
efficiency was calculated by transformation into E. coli as de-
scribed above (see Materials and Methods). The recombinants
were obtained by plating on chloramphenicol-ampicillin-con-
taining plates, and each recombinant was further analyzed by
DNA sequencing.
In 70% (23/33) of the recombinants of pSCR71, the left
breakpoint in the recombination zone was within the bcl-2 Mbr
(Fig. 2B). There were no cases where the 12-coding end of this
substrate joined with the Mbr. However, the recombination
frequency of molecules with a break at the Mbr and a second
break at the 23-signal coding end was 0.0042% (Table 1). We
also found nucleotide additions at the junctions of the recom-
binants and some joining events that utilize microhomology.
In actual patient t(14;18) translocations, the 23-coding end is
joined to the bcl-2 Mbr. In the case of the pSCR72 construct,
we positioned the 12/23-signals in such a way that we could test
for recombination of the other coding end, the 12-coding end,
with the bcl-2 Mbr. With this construct, 80% of the break-
points on the left side of the recombination zone were within
the Mbr (Fig. 2B), with a recombination frequency of
0.00678% (Table 1). Interestingly, on the right side of the
recombination zone, we found that the 12-coding end also can
join with the Mbr (frequency of 0.00102%) (Table 1). We
found nucleotide additions and microhomology usage at the
recombinant breakpoint junctions here also. Parenthetically,
three recombinants were found where the 12- to 23-signal
rearrangement occurred, but no Mbr recombination was
found; in these cases, the chloramphenicol resistance observed
was due to point mutations within the transcription terminator.
As above, here also we do not find any signal end joining to the
bcl-2 Mbr (Fig. 2B).
In a different construct, pSCR76, we paired the bcl-2 Mbr
sequence with a pair of 12/23-signals oriented for inversional
recombination with respect to one another (Fig. 2B). After
transfection into Reh cells and analysis of the recombinants,
we found, as above, that the Mbr is more fragile (76% of
recombinants within the Mbr) than the surrounding sequences,
with a recombination frequency of 0.00414%. Similar to
pSCR72, the 12-coding end joined with the Mbr, with a re-
combination frequency of 0.00159% (Table 1). Though the
coding end of the 12-signal was able to join with the Mbr, we
did not see any joining of the 23-coding end to the Mbr. The
TABLE 1. Comparison of breakpoint frequencies in recombinant plasmid molecules
Plasmida DAb
DACc with: % Recombinationd No. of molecules (% recombination)
with Mbr joined to the 12- or
23-signale
Breakpoint within
bcl-2 Mbr
Cut at the 12-
or 23-signal Mbr 12- or 23-signal
pSCR71 238,000 23 11 (23-signal) 0.00966 0.00462 10 (0.00420)
pSCR72 294,800 20 5 (12-signal) 0.00678 0.00170 3 (0.00102)
pSCR73 2,150,500 108 0 (23-signal) 0.00502 0.000047 0 (0.000047)
pSCR74 3,884,600 216 0 (12-signal) 0.00556 0.000026 0 (0.000026)
pSCR75 270,400 17 0 (23-signal) 0.00629 0.00037 0 (0.00037)
pSCR76 314,000 13 5 (12-signal) 0.00414 0.00159 5 (0.00159)
a The episomes (pSCR71 through pSCR76) were transfected into mammalian cells (Reh cells), recovered 48 h later, and analyzed in bacteria as described in Materials
and Methods.
b Substrate molecules that replicated in the Reh cells.
c Bacterial transformants that are ampicillin-chloramphenicol (doubly) resistant, also referred to as recombinants. The DAC column is subdivided according to the
left and right boundaries of recombination. The left boundary is the subset of double-resistant recombinants that have a breakpoint within the bcl-2 Mbr. The right
boundary is the subset of recombinants that utilize the 12-signal or 23-signal sequence for recombination.
d The % recombination of the Mbr is calculated by the equation (DAC of the Mbr/DA)  100 and is the recombination frequency for all events that utilize the Mbr.
The % recombination of the 12- or 23-signal is calculated by the equation (DAC of the 12- or 23-signal/DA)  100 and is the recombination frequency for all events
that utilize either the 12- or the 23-signal.
e The recombination frequencies of molecules with one break at the bcl-2 Mbr and a second break at a 12- or 23-signal are shown.
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generation of such recombinants would require three indepen-
dent double-stranded DNA ligation events to generate a com-
pletely intact recombinant plasmid—one at the retained signal
joint and two more at the two Mbr-to-coding-end junctions. In
summary, the studies described above show that either of the
two coding ends is capable of joining to the bcl-2 Mbr.
In vivo test for 12- or 23-signal end recombination with the
bcl-2Mbr. From the studies described above, we have seen that
signal ends are not able to join with the Mbr. Because two or
more independent ligation events would be required for the
joining of a signal end to the Mbr, the efficiency of such joining
might be expected to be lower than that of the single junction
events. Therefore, we analyzed another set of episomal sub-
strates, pSCR73 and pSCR74, for which a single ligation be-
tween a signal end and the Mbr would be sufficient to generate
the recombinant (Fig. 2B).
Results showed that, for both pSCR73 and pSCR74, most of
the breakpoints at the bcl-2 side of the recombination zone are
located within the Mbr (72% and 71%, respectively) and have
comparable recombination frequencies (0.00502% for pSCR73
and 0.00556% for pSCR74) (Fig. 2B and Table 1). We further
found that neither the 23-signal end of pSCR73 nor the 12-
signal end of pSCR74 can join with the Mbr (Fig. 2B). The
recombination frequency of the 23-signal end joining to the
Mbr in pSCR73 was undetectable and less than 0.000047%,
which is 	89-fold lower than that of pSCR71 (Table 1). Sim-
ilarly, the recombination frequency of the 12-signal end joining
to the Mbr in pSCR74 was less than 0.000026%, which is
	162-fold lower than that of pSCR71 (Table 1). Therefore,
signal ends appear not to be able to join to the Mbr. In these
recombinants, a random break accounts for the recovery on
the double-selection plates because this break is not located
adjacent to either recombination signal sequence (RSS). [The
cause of the random break is unknown, and these may arise
during replication. Such breaks are unlikely to initiate from the
signals, because signal ends do not consistently suffer nucleo-
lytic resection in V(D)J recombination within wild-type cells
(11).] It is also important to point out that in both pSCR73 and
pCSR74, the recombination signal close to the Mbr is a coding
end. These coding ends are not used for recombination to the
Mbr. This again may be due to the possible requirement of two
independent ligations to yield such a recombinant. Another
possibility is that after RAG cleavage at 12- and 23-signals, the
fragment containing the lambda region may be lost, so that the
12- or 23-coding ends of pSCR73 and pSCR74 may not be
available at all for rejoining.
We also tested another substrate, pSCR75, where the Mbr
could recombine with 12- and 23-signals oriented for inver-
sional recombination relative to each other. In pSCR75, the
orientation of the signal sequences is the reverse of that in
pSCR76 (Fig. 2B). We found that, in this case also, 17 out of
28 recombination events occurred at the Mbr, with a recom-
bination frequency of 0.00629% (Table 1). None of the recom-
bination events utilized the 12- or the 23-signal end. The re-
combination frequency was less than 0.00037%, which is 	12-
fold lower than that of pSCR71, where recombination occurs
between the Mbr and the 23-coding end (Table 1).
Since we were not able to detect any recombinants with a
signal end joined to the Mbr by a transformation assay, we
used a PCR assay to further screen for such recombinants. We
digested the recovered DNA with a restriction enzyme that
cleaves only in the zone between the Mbr and the 12/23-signals
to eliminate unrecombined DNA molecules. The PCR was
then carried out using the enzyme-digested DNA. Results
showed that there is no amplification of the digested transfec-
tion products (data not shown), further indicating that the
signal ends are not joined to the bcl-2 Mbr.
These results indicate that, unlike coding ends, signal ends
are unable to join with the bcl-2 Mbr, implying that they are
either already joined with one another to form a signal joint or
that they are bound by RAG proteins in a manner that is
distinct from the coding ends (1). Our results also show that
the break at the bcl-2 Mbr occurs independently of the break
at the 12/23-signal pair because the recombination rate and the
targeting to the Mbr are independent of whether there is only
a 12- or a 23-signal, or both, on the plasmid (30). The overall
recombination frequency for the Mbr is only slightly higher for
pSCR71 and pSCR72 than for pSCR73 to -76, consistent with
the fact that targeting to both the Mbr and a coding end
account for only about one-third of recombinants (30).
We also found that similar joining events occur even when
the bcl-2 Mbr is placed in reverse orientation relative to the
12/23-signals (pSCR77, -79, -81, -85, and -87) (data not shown).
These results indicate that either of the resulting two DNA
ends of the broken bcl-2 Mbr is capable of joining with either
coding end.
Sequences of junctions reveal T nucleotides. It has previ-
ously been noted that the bcl-2 Mbr translocations have a
distinct, highly significant junctional feature called T nucleo-
tides (where T stands for “templated”), in which the additions
are a direct or inverted repeat of a portion (1 to 10 nucleotides
[nt]) of one of the participating DNA ends with various num-
bers of mismatches (19, 30). The template for the T nucleo-
tides can be either from the intact sequences or from the
deleted portions and can be from either the top or the bottom
strands of any of the four involved DNA ends. These T nucle-
otides are sufficiently common that they represent a signature
feature of the in vivo t(14;18) translocations seen in patients.
In our study, we found nucleotide additions at the junctions
of recombinants. Some of these insertions appear to have re-
sulted from N nucleotide addition by TdT. Interestingly, many
of the junctions also had T nucleotides (Fig. 3). In our study,
we designated additions as T nucleotides when 3 or 4 nt of
perfect homology were present. In cases where the junctional
additions were 5 nt or more, a minimum of 80% homology was
required. The frequent presence of this signature feature in
our recombination substrates indicates that the t(14;18) trans-
location mechanism is recapitulated at the sequence level of
the break at the bcl-2 Mbr.
In vivo test of the ligase IV dependence of the 23-coding-end
recombination with the bcl-2 Mbr. In the minichromosomal
substrate studies of mammalian cells described above, we
noted that many of the recombinants utilized microhomology
during the joining process, suggesting that NHEJ is the mech-
anism of rejoining the breaks. It is well established that NHEJ
is involved in V(D)J recombination (7, 13, 25). Studies of
patients show that during t(14;18) translocation, the break at
chromosome 14 occurs during V(D)J recombination, and the
above-described and earlier intracellular minichromosomal
studies show that the breaks at the bcl-2 Mbr are generated by
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FIG. 3. T nucleotides are present at the junctions of the bcl-2 recombinants. The top strand of each substrate sequence is shown. The bold capital
letters represent nucleotides that are retained on the substrate. The double slashes indicate the breakpoints. The italicized capital letter sequences are
the nucleotide additions at the junction. T nucleotides are underlined, and the orientations are indicated by arrows. Mismatches within the T nucleotides
are represented in bold within the arrow-designated regions. The DNA (20 nt) deleted and immediately adjacent to the breakpoints from each end are
shown within parentheses and in small letters. The number at the left of each sequence indicates the name of that molecular clone.
6480
 o
n
 February 3, 2017 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
the RAG complex (30). In order to test whether NHEJ is
involved in t(14;18) translocation, we used human pre-B cells
that are genetically knocked out at the ligase IV gene (16).
We transfected two episomal substrates, pSCR45 and
pXW5, into the ligase IV knockout cells, N114P2 (16), and the
wild-type pre-B parental line, Nalm6. The DNA was harvested
at 48 h (Fig. 4). Recombination products were recovered and
analyzed by sequencing as described above. For pSCR45, we
found that in 71% of the cases, the left boundary of recombi-
nation occurred within the Mbr, with a recombination fre-
quency of 0.0027% in the wild-type, pre-B cells (Nalm6) (Fig.
4 and Table 2). In about 54% of the events, the right recom-
bination boundary break occurred at the 23-signal. The fre-
quency of molecules where a 23-coding end joined with the
Mbr was 0.002%. We also found T nucleotides at the junctions
of these recombinants.
Interestingly, when we transfected pSCR45 into the ligase
IV knockout cells, we found a dramatic reduction in the num-
ber of recombinants. We found only two recombinants, and of
those, only one had a breakpoint at the Mbr. The recombina-
tion frequency was reduced to 0.00016%, which is about 17-
fold lower than that of the wild-type cells (Table 2). More
importantly, there were no recombinants with a break at the
Mbr and a second break at either the 12- or the 23-signal
(recombination frequency of0.00016%) (Fig. 4 and Table 2).
These results indicate that ligase IV is likely to be the ligase
responsible for all or at least 95% of the rejoining events.
We found an even more dramatic difference when we trans-
fected pXW5, the one-signal substrate, into Nalm6 and
N114P2 cells. About 69% of the breaks occurred at the bcl-2
Mbr when pXW5 was harvested from Nalm6, with a recombi-
FIG. 4. Ligase IV is required for recombination between the bcl-2 Mbr and the signal ends. Episomes pSCR45 and pXW5 were transfected into
ligase IV knockout cells (N114P2) and the corresponding wild-type cells (Nalm6). (A) DNA was recovered 48 h later and analyzed. The Mbr region
is represented by a gray box. The white boxed regions adjacent to the Mbr are the flanking regions that are naturally adjacent to the Mbr in the
human chromosome. The 12-signal is indicated by an open triangle, and the 23-signal is indicated by a stippled triangle. The transcriptional
promoter is indicated by a short arrow above and parallel to the plasmid backbone. “stop” indicates the region of a transcription terminator, and
“cat” represents the chloramphenicol gene. (B) DA, number of substrate molecules that replicated in the Reh cells. The recombinants that are
ampicillin-chloramphenicol (doubly) resistant are classified according to the left and right boundaries of recombination. The left boundaries of
recombinants are grouped according to whether the break is within the Mbr or outside of it. The right boundaries of recombinants are grouped
by whether or not they utilize the 23-signal.
TABLE 2. Comparison of recombination frequencies of
recombinant plasmid molecules from Nalm6 and N114P2 cells
Plasmida
Location of
recombination
event
Recombination frequency (%)
Nalm6
cells
N114P2
cells
Fold
difference
pSCR45 MBR 0.0027 0.00016 17
23-signal 0.0021 0.00016 13
pXW5 MBR 0.0032 0.00034 9
a Episomes pSCR45 and pXW5 were transfected into mammalian cells (either
Nalm6 cells or N114P2 cells, which are ligase IV knockout derivatives of Nalm6),
recovered 48 h later, and analyzed in bacteria as described in Materials and
Methods. The recombination efficiency of pSCR45 is defined according to the
left and right boundaries of recombination. The left boundary is the recombi-
nation frequency of the Mbr, and the right boundary is the recombination
frequency of the 23-signal.
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nation frequency of 0.0032%. We found no recombinant when
we transfected the same episome into N114P2 cells, yielding a
recombination frequency of 0.00034% (Fig. 4B and Table 2).
These results further confirm the requirement of ligase IV.
The involvement of DNA ligase IV suggests that NHEJ is the
pathway to rejoin the breaks during the bcl-2 translocation. In
the absence of ligase IV, other ligases are unable to compen-
sate for it at the same level of efficiency.
DISCUSSION
Model for the events during the t(14;18) translocation.
There have been many unanswered questions about the t(14;
18) order of events and the nature of those events (21). Six
DNA ends (two coding ends, two signal ends, and two Mbr
ends) must be accounted for in this process, whereas the nor-
mal V(D)J recombination reactions require accounting for
only four (29). Can any one of the six ends join to any other of
the six? Is the specific RAG complex that cleaves the 12- and
23-signals the same one as that which cleaves the bcl-2 Mbr?
Our results showed that only coding ends, not signal ends,
can join with the bcl-2 Mbr. The recombinants that we ob-
served in the case of signal end substrates (pSCR73 and
pSCR74) did not involve the 12- or 23-signals. In these recom-
binants, the break on the left side of the recombination zone
was within the Mbr, but the break on the right side of the
recombination zone was not at the signal. Usually these right-
side breaks are between the two signals and far from either
signal. Occasionally, the breaks are far to the right side of the
rightmost signal boundary. Such breaks are highly unlikely to
initiate from the signals, as signal ends usually do not suffer
nucleolytic resection during the V(D)J recombination within
wild-type cells (11).
The fact that the signal ends do not participate in the joining
to either Mbr end is most easily explained either by the fact
that they have already been joined to form a signal joint or by
the fact that they have been bound by RAGs (1, 18). The fact
that any of the four remaining ends (two coding ends and two
Mbr ends) can join to any other of the four raises the possi-
bility that there could be a four-ended intermediate just prior
to the ligation of these four ends (22). Substrates, such as those
used here, permit all combinations of ends to be assessed.
However, in the chromosome, cell viability would be at risk if
an immunoglobulin (Ig) heavy-chain 12-coding end joined to
the Mbr, because this would yield one dicentric and one acen-
tric chromosome. Hence, the substrates used here permit in-
ferences that chromosomal observations cannot.
The reliance on DNA ligase IV indicates that NHEJ is
responsible for the rejoining of these four ends. The sequence
features of the chromosomal and minichromosomal transloca-
tion junctions, including P nucleotides due to hairpin opening
by the Artemis/DNA-PKcs complex and template-independent
addition due to TdT, also indicate that NHEJ is the joining
pathway (26, 33).
Based on these findings, a detailed model for the events at
the t(14;18) translocation can now be formulated (Fig. 5). In
this model, one RAG complex cuts both strands independently
at the bcl-2 Mbr. We know that the RAG complex can cut both
strands (top and bottom strands) of the Mbr independently in
vitro (30, 30a). We have also seen RAG cleavage on short
double-stranded DNA containing bubbles or loops, indicating
that the RAG complex generally cleaves at single- or double-
strand transitions (30a). This cleavage does not involve hairpin
formation at the break sites, in contrast to action at synapsed
RSS sites. In addition, we have seen RAG-induced double-
strand break (DSB) formation on 248- to 339-bp DNA frag-
ments containing the bcl-2 Mbr structure, and these fragments
do not have any recombination signals. Hence, no synapsis of
the Mbr with any RSS can occur.
A second RAG complex simultaneously cuts the 12- and
23-signals in the standard synapsis that is thought to form
during V(D)J recombination (7). We have observed 12- and
23-signal recombination events on substrates that also carry
the Mbr, and their recombination is indistinguishable from
that of substrates that do not carry the Mbr. In such a standard
V(D)J recombination reaction, there is a period of time when
there is a four-ended intermediate containing two signal ends
and two coding ends. Such a four-ended intermediate is func-
tionally known to exist because any coding end can join with
any signal end to form not only the standard signal and coding
joints but also hybrid joints and open-and-shut joints (22).
There is also biochemical evidence to suggest the existence of
such intermediates (1, 18). The fact that we did not find signal
end recombination with the Mbr suggests that the two signal
ends are ligated to form a signal joint or are synapsed by the
RAG complex such that they cannot be used for ligation with
the Mbr ends. This also rules out any direct attack by the
RAG–12-signal end–23-signal end complex on the Mbr to cre-
ate the DSB there, consistent with our observation that Mbr
breaks are not stimulated by 12- or 23-signals located nearby
on cellular substrates.
Since we found that both the bcl-2 Mbr and the RSS are
independently cleaved by RAGs, the question arises whether
there is a place in the nucleus where RAG-mediated cleavage
occurs. This appears to be unlikely, based on observations in
human and yeast cells. For example, the human MLL gene on
chromosome 11 can break and join with 38 different partners,
leading to the development of infant acute lymphoblastic leu-
kemia (31, 32). If the MLL gene has 38 partners, then it seems
unlikely that the MLL gene and all 38 partners are positioned
adjacently in the human nucleus. Therefore, in the case of the
MLL gene, the search for and rejoining of ends appear to
involve a large fraction of the genome and, hence, the nucleus.
We suspect that the same considerations apply to the t(14;18)
translocation. In addition, during yeast homologous recombi-
nation events that result in intrachromosomal deletion or re-
ciprocal translocation, the broken ends of mitotic chromo-
somes are free to search the entire genome for appropriate
partners; thus, mitotic chromosomes are not functionally con-
fined to isolated domains of the nucleus (17).
One might wonder to what extent the RAG proteins remain
bound to the coding ends and/or to the Mbr ends following
cleavage. Signal ends are known to be held relatively tightly in
a postcleavage complex. In contrast, the binding of coding ends
in such postcleavage complexes may not be as tight (1, 18). In
the small proportion of D-J recombination events that result in
translocations, we suspect that these are cases where the D and
J coding ends are released prematurely. There is also no rea-
son to believe that the binding of the RAG complex to the Mbr
is tight, following the nicking events on the top or bottom
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strand of the Mbr (30a). Hence, we do not necessarily believe
that a RAG complex at the D-J coding ends and another at the
Mbr are involved in the synapsis of these two sites. Rather, we
believe that the ends may come together in a RAG-indepen-
dent manner, probably by NHEJ. If the D, J, and two Mbr ends
are the only ones in the nucleus, their rejoining by NHEJ in
any possible configuration may not be so surprising in light of
data on simultaneous breaks in the genomes of yeast (17).
One might also consider why the t(14;18) translocation does
not involve the V and D rather than the D and J segments.
Distance issues are one possibility. Because we do not know
the full limits over which the Ig heavy-chain enhancer and
locus control regions act, it is difficult to rule this possibility in
or out (27). Nicking efficiency by the RAGs at the V-D pairs
versus the D-J pairs is a second factor. Nicking at the V seg-
ment and the upstream side of the D segment is not as efficient
as it is at the downstream side of the D segment and at the J
segment (10, 37–39). Part of this is due to lower signal se-
quence strength, but part is due to coding-end sequence effects
(14). This factor could contribute as much as 2 orders of
magnitude preference to the use of D-J pairs instead of V-D
pairs.
In addition to the P nucleotides (due to hairpin opening)
and the N nucleotides (due to TdT), we also found T nucleo-
tides at the junctions of the bcl-2 recombinants. Such T nucle-
otides are a signature feature of t(14;18) translocation in fol-
licular lymphoma patients (19, 29). The reproduction of such T
nucleotides in the episomal recombinants indicates that these
recombinants recapitulate the fine structural features of this
translocation process.
The final phase of the translocation process is the joining of
the two coding ends with the two Mbr ends. We have shown
that this is dependent on the XRCC4-DNA ligase IV complex
and hence is a normal NHEJ process at both joints (see below).
Ligase IV dependence of chromosomal translocations.
NHEJ has been suspected to be important for many translo-
cations, and the studies here support that. This issue has been
complicated by the fact that in NHEJ null mice, translocations
(none that correspond to the bcl-2 translocation) can still be
detected, and it has been unclear what enzymes replace the
NHEJ components under these circumstances (6). Alternative
methods for end joining may be used when NHEJ is absent
(29). In the absence of ligase IV or XRCC4, the ligation of
some translocation must be done by either DNA ligase I or III.
Ligase I can ligate when the two nicks of a DSB are sufficiently
far apart. Ligase III can ligate DSBs when they are compatible
(4). Our studies here do not shed light on this. Rather, we only
know that when ligase IV is absent, the efficiency of these
FIG. 5. Biochemical model for the mechanism of the t(14;18) chromosomal translocation. The aspects of the mechanism depicted by the two
question marks in Fig. 1 are significantly clarified by this study. Our previous work indicated that the RAG cleavage at the Mbr (denoted by “RAG
complex #2” and downward arrows) is independent of the RAG cleavage at the paired 12/23-signal pair (denoted by “RAG complex #1”), and
the work here has confirmed and extended this point (30). Because the signal ends do not recombine with the Mbr, they may already be joined;
alternatively, they may still be bound by the RAG complex that cleaved them (1). In either case, they are unavailable to recombine with the Mbr.
This reduces the translocation intermediate step to a four-DNA-end problem rather than a six-DNA-end problem. NHEJ is the pathway for
rejoining the ends, based on the new findings from the present study, which are shown in italics.
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alternative pathways is not adequate to quantitatively restore
the level of the bcl-2 translocation. Hence, the efficiencies of
these alternative enzymatic methods of joining are not as high
as that of NHEJ for this particular translocation process.
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